Cancer Drug Keytruda a New Weapon Against Advanced Lung Tumors
SUNDAY, June 3, 2018 (HealthDay News) — A cancer drug that boosts the immune system outperforms chemotherapy in fighting advanced lung cancer, a new trial shows. Keytruda (pembrolizumab) extended life four to eight months longer than chemotherapy in lung cancer patients whose immune systems had been duped by their cancerContinue Reading










